Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|September 9, 2024
Assessing the inhibitory effects of some secondary amines, thioureas and 1,3-dimethyluracil conjugates of (-)-cytisine and thermopsine on the RNA-dependent RNA polymerase of SARS-CoV-1 and SARS-CoV-2Yeh Chen, Mann-Jen Hour, Chen-Sheng Lin, et al.Virus Research|September 28, 2019
Antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63Jing-Ru Weng, Chen-Sheng Lin, Hsueh-Chou Lai, et al.Journal of the American Chemical Society|August 25, 2017
Intraligand Charge Transfer Sensitization on Self-Assembled Europium Tetrahedral Cage Leads to Dual-Selective Luminescent Sensing toward Anion and CationCui-Lian Liu, Rui-Ling Zhang, Chen-Sheng Lin, et al.Biomolecules & Therapeutics|September 29, 2018
<i>Cis-3-O-p-</i>hydroxycinnamoyl Ursolic Acid Induced ROS-Dependent p53-Mediated Mitochondrial Apoptosis in Oral Cancer CellsChing-Ying Wang, Chen-Sheng Lin, Chun-Hung Hua, et al.Viruses|January 8, 2025
Discovery of Potent Dengue Virus NS2B-NS3 Protease Inhibitors Among Glycyrrhizic Acid Conjugates with Amino Acids and Dipeptides EstersYu-Feng Lin, Hsueh-Chou Lai, Chen-Sheng Lin, et al.Viruses|November 6, 2019
The Rescue and Characterization of Recombinant, Microcephaly-Associated Zika Viruses as Single-Round Infectious ParticlesChien-Yi Lu, Chen-Sheng Lin, Hsueh-Chou Lai, et al.International Journal of Molecular Sciences|September 23, 2022
Glycyrrhizic Acid Derivatives Bearing Amino Acid Residues in the Carbohydrate Part as Dengue Virus E Protein Inhibitors: Synthesis and Antiviral ActivityMann-Jen Hour, Yeh Chen, Chen-Sheng Lin, et al.Bioorganic & Medicinal Chemistry Letters|January 19, 2024
Inhibition of dengue viruses by N-methylcytisine thio derivatives through targeting viral envelope protein and NS2B-NS3 proteaseChen-Sheng Lin, Chih-Hao Lu, Tsai-Hsiu Lin, et al.Transplantation|November 16, 2010
Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studiesChristian P Larsen, Josep Grinyó, José Medina-Pestana, et al.Archives of Internal Medicine|January 14, 2004
Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analysesCharles H Hennekens, Frank M Sacks, Andrew Tonkin, et al.Pageof 6